Page 13 - Sanger Sequencing News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Psomagen, Inc. products, product reviews and application articles on SelectScience.

The global electric bus market is set to gain impetus from the surging fuel costs and higher usage of unrefined petroleum. These have further propelled the

/PRNewswire/ -- The "Short-Read Sequencing - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Amid the...

Dublin, May 25, 2021 (GLOBE NEWSWIRE) -- The "Short-Read Sequencing - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Amid the COVID-19 crisis, the global market for Short-Read Sequencing estimated at US$10.6 Billion in the year 2020, is projected to reach a revised size of US$20.4 Billion by 2027, growing at a CAGR of 9.9% over the period 2020-2027. Next-Generation Sequencing, one of the segments analyzed in the report, is projected to record 9.5% CAGR and reach US$13.5 Billion by the end of the analysis period. After an ea...

Product News: Molzym announces FDA Breakthrough Device Designation for its molecular diagnostic test system FDA Breakthrough Device Designation for Sepsis, Joint & Implant Infections, Infective Endocarditis, Bacterial Meningitis 13 May 2021 Molzym’ s unique technology for molecular microbial diagnostics was granted Breakthrough Device Designation (BDD) by the FDA in light of its capacity to aid the diagnosis of Bloodstream Infection/Sepsis, Joint and Implant Infections, Infective Endocarditis, and Bacterial Meningitis as an adjunct to the current standard of care. The FDA BDD Program aims a...